Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)

John Conibear; Brendan Chia; Yenting Ngai; Andrew Tom Bates; Nicholas Counsell; Rushil Patel; David Eaton; Corinne Faivre-Finn; John Fenwick; Martin Forster; Gerard G. Hanna; Susan Harden; Philip Mayles; Syed Moinuddin; David Landau; Kevin Franks; Merina Ahmed; Stephen Harrow; Ruheena Mendes; Paul Hatfield; Yat Man Tsang; Ka Man Mak; Laura Farrelly; John Conibear; Brendan Chia; Yenting Ngai; Andrew Tom Bates; Nicholas Counsell; Rushil Patel; David Eaton; Corinne Faivre-Finn; John Fenwick; Martin Forster; Gerard G. Hanna; Susan Harden; Philip Mayles; Syed Moinuddin; David Landau

doi:10.1136/bmjopen-2017-020690corr1

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)

John Conibear, Brendan Chia, Yenting Ngai, Andrew Tom Bates, Nicholas Counsell, Rushil Patel, David Eaton, Corinne Faivre-Finn, John Fenwick, Martin Forster, Gerard G. Hanna, Susan Harden, Philip Mayles, Syed Moinuddin, David Landau, Kevin Franks, Merina Ahmed, Stephen Harrow, Ruheena Mendes, Paul HatfieldYat Man Tsang, Ka Man Mak, Laura Farrelly, John Conibear, Brendan Chia, Yenting Ngai, Andrew Tom Bates, Nicholas Counsell, Rushil Patel, David Eaton, Corinne Faivre-Finn, John Fenwick, Martin Forster, Gerard G. Hanna, Susan Harden, Philip Mayles, Syed Moinuddin, David Landau

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	BMJ Open
Volume	9
Issue number	5
DOIs	https://doi.org/10.1136/bmjopen-2017-020690corr1
Publication status	Published - May 2019

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmjopen-2017-020690corr1

Cite this

Conibear, J., Chia, B., Ngai, Y., Bates, A. T., Counsell, N., Patel, R., Eaton, D., Faivre-Finn, C., Fenwick, J., Forster, M., Hanna, G. G., Harden, S., Mayles, P., Moinuddin, S., Landau, D., Franks, K., Ahmed, M., Harrow, S., Mendes, R., ... Landau, D. (2019). Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018). BMJ Open, 9(5). https://doi.org/10.1136/bmjopen-2017-020690corr1

Conibear, John ; Chia, Brendan ; Ngai, Yenting et al. / Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018). In: BMJ Open. 2019 ; Vol. 9, No. 5.

@article{ad104ac9f3794fc5a3180119f3fa0802,

title = "Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)",

author = "John Conibear and Brendan Chia and Yenting Ngai and Bates, {Andrew Tom} and Nicholas Counsell and Rushil Patel and David Eaton and Corinne Faivre-Finn and John Fenwick and Martin Forster and Hanna, {Gerard G.} and Susan Harden and Philip Mayles and Syed Moinuddin and David Landau and Kevin Franks and Merina Ahmed and Stephen Harrow and Ruheena Mendes and Paul Hatfield and Tsang, {Yat Man} and Mak, {Ka Man} and Laura Farrelly and John Conibear and Brendan Chia and Yenting Ngai and Bates, {Andrew Tom} and Nicholas Counsell and Rushil Patel and David Eaton and Corinne Faivre-Finn and John Fenwick and Martin Forster and Hanna, {Gerard G.} and Susan Harden and Philip Mayles and Syed Moinuddin and David Landau",

year = "2019",

month = may,

doi = "10.1136/bmjopen-2017-020690corr1",

language = "English",

volume = "9",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ ",

number = "5",

}

Conibear, J, Chia, B, Ngai, Y, Bates, AT, Counsell, N, Patel, R, Eaton, D, Faivre-Finn, C, Fenwick, J, Forster, M, Hanna, GG, Harden, S, Mayles, P, Moinuddin, S, Landau, D, Franks, K, Ahmed, M, Harrow, S, Mendes, R, Hatfield, P, Tsang, YM, Mak, KM, Farrelly, L, Conibear, J, Chia, B, Ngai, Y, Bates, AT, Counsell, N, Patel, R, Eaton, D, Faivre-Finn, C, Fenwick, J, Forster, M, Hanna, GG, Harden, S, Mayles, P, Moinuddin, S & Landau, D 2019, 'Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)', BMJ Open, vol. 9, no. 5. https://doi.org/10.1136/bmjopen-2017-020690corr1

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018). / Conibear, John; Chia, Brendan; Ngai, Yenting et al.
In: BMJ Open, Vol. 9, No. 5, 05.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018)

AU - Conibear, John

AU - Chia, Brendan

AU - Ngai, Yenting

AU - Bates, Andrew Tom

AU - Counsell, Nicholas

AU - Patel, Rushil

AU - Eaton, David

AU - Faivre-Finn, Corinne

AU - Fenwick, John

AU - Forster, Martin

AU - Hanna, Gerard G.

AU - Harden, Susan

AU - Mayles, Philip

AU - Moinuddin, Syed

AU - Landau, David

AU - Franks, Kevin

AU - Ahmed, Merina

AU - Harrow, Stephen

AU - Mendes, Ruheena

AU - Hatfield, Paul

AU - Tsang, Yat Man

AU - Mak, Ka Man

AU - Farrelly, Laura

AU - Conibear, John

AU - Chia, Brendan

AU - Ngai, Yenting

AU - Bates, Andrew Tom

AU - Counsell, Nicholas

AU - Patel, Rushil

AU - Eaton, David

AU - Faivre-Finn, Corinne

AU - Fenwick, John

AU - Forster, Martin

AU - Hanna, Gerard G.

AU - Harden, Susan

AU - Mayles, Philip

AU - Moinuddin, Syed

AU - Landau, David

PY - 2019/5

Y1 - 2019/5

U2 - 10.1136/bmjopen-2017-020690corr1

DO - 10.1136/bmjopen-2017-020690corr1

M3 - Article

SN - 2044-6055

VL - 9

JO - BMJ Open

JF - BMJ Open

IS - 5

ER -

Conibear J, Chia B, Ngai Y, Bates AT, Counsell N, Patel R et al. Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer (vol 8, e020690, 2018). BMJ Open. 2019 May;9(5). doi: 10.1136/bmjopen-2017-020690corr1